These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 21314126)
1. Suppression of hepatitis B virus x protein-mediated tumorigenic effects by ursolic Acid. Wu HY; Chang CI; Lin BW; Yu FL; Lin PY; Hsu JL; Yen CH; Liao MH; Shih WL J Agric Food Chem; 2011 Mar; 59(5):1713-22. PubMed ID: 21314126 [TBL] [Abstract][Full Text] [Related]
2. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model. Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898 [TBL] [Abstract][Full Text] [Related]
3. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. Shyu MH; Kao TC; Yen GC J Agric Food Chem; 2010 May; 58(10):6110-8. PubMed ID: 20415421 [TBL] [Abstract][Full Text] [Related]
4. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7]. Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135 [TBL] [Abstract][Full Text] [Related]
5. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor. Yang L; Liu X; Lu Z; Yuet-Wa Chan J; Zhou L; Fung KP; Wu P; Wu S Cancer Lett; 2010 Dec; 298(1):128-38. PubMed ID: 20630652 [TBL] [Abstract][Full Text] [Related]
6. [Biological impact of the COOH-terminal 40 amino acid deletions of hepatitis B virus X protein in hepatocellular carcinoma cells]. Liu XH; Lin J; Cao XZ; Zheng JM; Chen Y; Zhu MH Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):825-30. PubMed ID: 15949399 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695 [TBL] [Abstract][Full Text] [Related]
8. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings. Kang-Park S; Lee JH; Shin JH; Lee YI Biochem Biophys Res Commun; 2001 May; 283(2):303-7. PubMed ID: 11327698 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the tumorigenicity of the X gene of hepatitis B virus in a nontransformed hepatocyte cell line and the effects of cotransfection with a murine p53 mutant equivalent to human codon 249. Oguey D; Dumenco LL; Pierce RH; Fausto N Hepatology; 1996 Nov; 24(5):1024-33. PubMed ID: 8903370 [TBL] [Abstract][Full Text] [Related]
10. Expression of HBX, an oncoprotein of hepatitis B virus, blocks reoviral oncolysis of hepatocellular carcinoma cells. Park EH; Koh SS; Srisuttee R; Cho IR; Min HJ; Jhun BH; Lee YS; Jang KL; Kim CH; Johnston RN; Chung YH Cancer Gene Ther; 2009 May; 16(5):453-61. PubMed ID: 19096445 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Sirma H; Giannini C; Poussin K; Paterlini P; Kremsdorf D; Bréchot C Oncogene; 1999 Aug; 18(34):4848-59. PubMed ID: 10490818 [TBL] [Abstract][Full Text] [Related]
13. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. Chan DW; Ng IO J Pathol; 2006 Feb; 208(3):372-80. PubMed ID: 16353167 [TBL] [Abstract][Full Text] [Related]
14. Antimutagenicity of ursolic acid and oleanolic acid against doxorubicin-induced clastogenesis in Balb/c mice. Aparecida Resende F; de Andrade Barcala CA; da Silva Faria MC; Kato FH; Cunha WR; Tavares DC Life Sci; 2006 Aug; 79(13):1268-73. PubMed ID: 16647723 [TBL] [Abstract][Full Text] [Related]
15. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib. Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus X protein sensitizes UV-induced apoptosis by transcriptional transactivation of Fas ligand gene expression. Kim SY; Kim JK; Kim HJ; Ahn JK IUBMB Life; 2005 Sep; 57(9):651-8. PubMed ID: 16203685 [TBL] [Abstract][Full Text] [Related]
17. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Tu H; Bonura C; Giannini C; Mouly H; Soussan P; Kew M; Paterlini-Bréchot P; Bréchot C; Kremsdorf D Cancer Res; 2001 Nov; 61(21):7803-10. PubMed ID: 11691796 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of ursolic acid and oleanolic acid in leukemic cells. Ovesná Z; Kozics K; Slamenová D Mutat Res; 2006 Aug; 600(1-2):131-7. PubMed ID: 16831451 [TBL] [Abstract][Full Text] [Related]
19. [Polymorphism of hepatitis B virus x gene in hepatocellular carcinoma patients and the biological effects of HBx gene with deletion varations on QSG7701 cells]. Zhu PA; Tan DM; Peng ZT; Liu F; Song L Zhonghua Gan Zang Bing Za Zhi; 2008 Jan; 16(1):7-11. PubMed ID: 18226335 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally. Ou DP; Tao YM; Chang ZG; Tang FQ; Yang LY Dig Liver Dis; 2006 Apr; 38(4):262-7. PubMed ID: 16461023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]